Anatomical Therapeutic Chemical • V03AF08 • palifermin

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various

V01 Allergens

V03 All other therapeutic products

V03A All other therapeutic products

V03AB Antidotes

V03AC Iron chelating agents

V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia

V03AF Detoxifying agents for antineoplastic treatment

V03AF01 mesna Indicated for: prevention of urothelial toxicity

V03AF02 dexrazoxane Indicated for: protection against chemotherapy or radiotherapy toxicity

V03AF03 calcium folate Indicated for: reduction of antifolate toxicity; folate deficiency

V03AF05 amifostine Indicated for: protection against chemotherapy or radiotherapy toxicity

V03AF07 rasburicase Indicated for: hyperuricemia in tumor lysis syndrome

V03AF08 palifermin Indicated for: mucositis; Kawasaki disease

V03AF09 glucarpidase Indicated for: methotrexate toxicity

V03AF11 arginine + lysine Indicated for: renal protection in radioligand therapy

V03AG Drugs for treatment of hypercalcemia

V03AH Drugs for treatment of hypoglycemia

V03AK Tissue adhesives

V03AM Drugs for embolisation

V03AN Medical gases

V03AX Other therapeutic products

V03AZ Nerve depressants

V04 Diagnostic agents

V06 General nutrients

V07 All other non-therapeutic products

V08 Contrast media

V09 Diagnostic radiopharmaceuticals

V10 Therapeutic radiopharmaceuticals

V20 Surgical dressings